节点文献

关于医疗机构中药复方新药开发的探讨

Considerations on research and development of new drug compound of Chinese medicine from medical institution

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 罗李娜陈更新

【Author】 LUO Li-na;CHEN Geng-xin;New Drug Development Center, Guangdong Provincial Hospital of Chinese Medicine & the Second Clinical College of Guangzhou University of Chinese Medicine;

【机构】 广东省中医院暨广州中医药大学第二附属医院新药开发中心

【摘要】 中药新药的开发是实现中医药现代化的关键,医疗机构是中药复方新药开发的源头。本文对医疗机构中药复方新药开发的现状、存在的相关问题进行分析,指出应明确临床定位,建立规范化的临床疗效评价方法以及中药复方新药开发平台,提供有利条件促成品种的转化,促进中药复方新药的开发、转化。

【Abstract】 The key to realize modernization of Chinese medicine is develop of new drug of Chinese medicine. Medical institution is the source of the development of Chinese medicine compound. In this paper, the current situation and related issues of new drug development of Chinese medicine compound in medical institution were analyzed. Clinical positioning should be defined. The normalized clinical curative effect evaluation method and development platform of Chinese medicine compound should be established. Providing favorable conditions contribute to translation, then benefit to the development and translation of Chinese medicine compound.

【基金】 广东省省级科技计划项目(2014A020221070)
  • 【文献出处】 中国新药与临床杂志 ,Chinese Journal of New Drugs and Clinical Remedies , 编辑部邮箱 ,2017年05期
  • 【分类号】R288
  • 【被引频次】3
  • 【下载频次】512
节点文献中: 

本文链接的文献网络图示:

本文的引文网络